# OnCo record garnet (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/garnet/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "garnet", "NCT02715284" ;
  schema:name "GARNET"@en ;
  schema:description "GARNET showed that the PD-1 antibody dostarlimab produced lasting responses in about four in ten women with mismatch repair-deficient endometrial cancer that had returned after chemotherapy, which won the drug its first approvals."@en ;
  schema:url <https://onco.cc/trials/garnet/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02715284> ;
  onco:status "positive" ;
  onco:tag "subtype-trials" ;
  onco:phase "1" ;
  onco:cancers <https://onco.cc/cancers/endometrial-mmr-deficient/>, <https://onco.cc/cancers/endometrial/> ;
  onco:drugs <https://onco.cc/drugs/dostarlimab/> ;
  onco:companies <https://onco.cc/companies/gsk/> ;
  onco:people <https://onco.cc/people/ana-oaknin/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-garnet-dostarlimab-oaknin-jama-oncol-2020/> .